Follow The Filings

ADCT position history

The shares of Adc Therapeutics (ADCT) that DAFNA Capital Management LLC reported in each quarter’s 13F.

Equity, SHS

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q2: 204,081 shares, $645K, 0.15% of portfolio, New
  2. 2024 Q3: 204,081 shares, $643K, 0.15% of portfolio
  3. 2024 Q4: 224,081 shares, $446K, 0.11% of portfolio, Add +9.8%
  4. 2025 Q1: 224,081 shares, $316K, 0.09% of portfolio
  5. 2025 Q2: 122,081 shares, $327K, 0.09% of portfolio, Reduce −45.5%
  6. 2025 Q3: 122,081 shares, $488K, 0.12% of portfolio
  7. 2025 Q4: 77,081 shares, $272K, 0.06% of portfolio, Reduce −36.9%
  8. 2026 Q1: 72,081 shares, $270K, 0.06% of portfolio, Reduce −6.5%
  9. 2026 Q2: 77,081 shares, $82K, 0.02% of portfolio, Add +6.9%
  10. 2026 Q3: 57,081 shares, $70K, 0.01% of portfolio, Reduce −25.9%
Holdings date Value % of holdings Shares Filing date All 13F holders